Today: 15 May 2026

CoreWeave stock slips with AI-linked tech as year-end rally cools

CoreWeave stock slips with AI-linked tech as year-end rally cools

CoreWeave shares fell about 1% to $75.62 in late-morning New York trading Monday, tracking declines in tech and AI stocks as the Nasdaq slipped 0.6%. The company traded between $73.03 and $77.75 on volume of 7 million shares. Nvidia shares dropped 1.6%. Investors remain focused on CoreWeave’s heavy capital spending and recent $2.25 billion convertible note offering.
29 December 2025
···
Enbridge gets a fresh 15-to-1 “scalable risk” setup as Stock Traders Daily posts new AI signals

Enbridge gets a fresh 15-to-1 “scalable risk” setup as Stock Traders Daily posts new AI signals

Stock Traders Daily on Dec. 29 issued a trading note on Enbridge Inc (ENB), citing a 15.2:1 risk-reward setup and detailing entry, target, and stop-loss levels for multiple strategies. The firm also flagged a “mid-channel oscillation” pattern. A Dec. 27 note set an 8.9:1 risk-reward profile for the Invesco MSCI EAFE Income Advantage ETF (EFAA), outlining specific price signals and targets.
29 December 2025
·
UPS stock slips under $100 — and its 6.6% dividend is back in the spotlight

UPS stock slips under $100 — and its 6.6% dividend is back in the spotlight

UPS shares fell 0.6% to $99.91 Monday morning, keeping its dividend yield near 6.6% as investors questioned payout sustainability. The company reported $21.4 billion in third-quarter revenue and $2.74 billion in free cash flow for the first nine months of 2025. UPS aims for $3.5 billion in annual cost savings next year and plans to cut Amazon-related deliveries by more than half by late 2026.
29 December 2025
··
Costco stock slips as year-end trading thins; next catalyst is Jan. 7 sales report

Costco stock slips as year-end trading thins; next catalyst is Jan. 7 sales report

Costco shares slipped 0.3% to $870.91 in late-morning trading Monday as U.S. retail stocks eased. Investors are watching for Costco’s December sales report, scheduled for Jan. 7 after market close. The S&P Retail ETF fell 0.6%, while Walmart rose 0.6% and Target dropped 0.8%. Markets remain quiet ahead of Fed minutes and jobless claims later this week.
29 December 2025
··
Citi stock slides in thin year-end trade as rate-cut bets return to focus

Citi stock slides in thin year-end trade as rate-cut bets return to focus

Citigroup shares dropped 1.4% to $118.75 Monday morning, underperforming other major U.S. banks as financial stocks slipped in thin holiday trading. The Financial Select Sector SPDR ETF fell 0.5%. Investors are watching Fed minutes this week and Citi’s Jan. 14 earnings call for direction. Treasury yields hovered just above 4.1% as markets priced in further Fed rate cuts.
29 December 2025
··
Sam Walton’s trust play resurfaces as Walmart gets the “never sell” treatment

Sam Walton’s trust play resurfaces as Walmart gets the “never sell” treatment

Walmart shares rose 0.4% to $112.21 in late morning trading, up 24% in 2025. Financial commentators are highlighting how Sam Walton placed shares in family trusts, helping the Walton heirs retain control. The three surviving Walton children each hold over $100 billion, according to Bloomberg data. Some analysts say Walmart stock tends to outperform in downturns as shoppers seek lower prices.
29 December 2025
Nike stock slips as UBS flags better brand signals but keeps neutral stance

Nike stock slips as UBS flags better brand signals but keeps neutral stance

Nike shares slipped 0.3% to $60.77 in New York after UBS reiterated its Neutral rating and $62 price target. The stock has been volatile since Nike reported a 17% drop in China sales and warned of further margin pressure from tariffs and discounting. UBS’s survey found improved product availability and brand perception, but analysts say recovery may take longer than investors expect.
29 December 2025
··
UnitedHealth stock slips as WSJ flags Optum mail-order refills ahead of 2026 guidance

UnitedHealth stock slips as WSJ flags Optum mail-order refills ahead of 2026 guidance

UnitedHealth shares slipped 0.2% to $331.19 after a Wall Street Journal report said insurer-owned mail-order pharmacies, including UnitedHealth’s, dispensed billions in excess prescription drugs to Medicare patients. The Journal found mail-order pharmacies made up 9% of Medicare prescriptions but 37% of excess drugs from 2021 to 2023. Investors await UnitedHealth’s Jan. 27 results and 2026 guidance.
29 December 2025
1 … 982 983 984 985 986 … 1,937

Stock Market Today

  • Novo Nordisk Stock Review: Mixed Returns Spotlight Valuation Debate
    May 14, 2026, 11:01 PM EDT. Novo Nordisk (NYSE:NVO) shares have presented a mixed performance with a 12.6% decline year to date but a recent 16.5% rebound over the past month. The Danish pharmaceutical giant, known for its Diabetes and Obesity Care products, reported revenues of $327.8 billion and a net income of $121.96 billion. Despite a one-year total shareholder return drop of 28.5%, some analysts see it as 51.8% undervalued with a fair value estimate near $95 per share, almost double its current trading price of $45.80. However, near-term challenges like intensifying competition, pricing pressures, and potential impacts of U.S. pricing reforms on key drugs temper optimism. Investors are urged to weigh these risks alongside durable profit margins and moderated growth forecasts to assess long-term prospects.

Latest articles

US Stock Market Today After Hours: Why the Dow Reclaimed 50,000 as AI Stocks Drove Wall Street Higher

US Stock Market Today After Hours: Why the Dow Reclaimed 50,000 as AI Stocks Drove Wall Street Higher

15 May 2026
The Dow closed above 50,000 for the first time Thursday, rising 370 points as AI-driven gains lifted U.S. stocks to record highs. Cisco surged after raising its revenue outlook and announcing $9 billion in AI infrastructure orders, while Nvidia jumped 4.4% on U.S. approval to sell chips to China. Cerebras Systems soared 68% in its market debut. Not all chipmakers advanced, with Qualcomm, Intel, Sandisk, and Micron falling sharply.
Xanadu Quantum Technologies Stock Gets Its First Public Earnings Test—and Losses Still Rule

Xanadu Quantum Technologies Stock Gets Its First Public Earnings Test—and Losses Still Rule

15 May 2026
Xanadu Quantum Technologies reported first-quarter revenue of $2.8 million, up from $0.7 million a year earlier, but net loss widened to $20.6 million. Shares rose 1.9% to $15.13 in late U.S. trading before falling over 3% after hours. The company ended March with $272.5 million in cash and plans a $300 million at-the-market facility. Xanadu began trading on Nasdaq and TSX under XNDU on March 27.
Sidus Space Stock Jumps After Q1 Revenue Rises 51%, But Losses Still Loom

Sidus Space Stock Jumps After Q1 Revenue Rises 51%, But Losses Still Loom

15 May 2026
Sidus Space reported first-quarter revenue of $359,000, up 51% from a year earlier, and a net loss of $5.2 million, narrowing from $6.4 million. Shares rose about 12% after results. Cash stood at $27.3 million at March 31, down from $43.2 million at year-end. The company raised $58.5 million in a direct share offering after the quarter closed.
Google Stock Just Hit a Record. Why Alphabet Shares Slipped Anyway

Google Stock Just Hit a Record. Why Alphabet Shares Slipped Anyway

15 May 2026
Alphabet Class A shares fell 0.4% to $401.07 on Thursday, pausing after a record run even as the S&P 500 and Nasdaq hit new highs. Investors weighed Google’s AI and cloud gains against persistent interest-rate concerns, with profit-taking outweighing news of a new robotics partnership with Fanuc. Alphabet’s market value stood near $4.86 trillion. Google Services revenue rose 16% last quarter, while Google Cloud jumped 63%.
Go toTop